83 related articles for article (PubMed ID: 27694707)
21. Development and evaluation of an articulated registration algorithm for human skeleton registration.
Yip S; Perk T; Jeraj R
Phys Med Biol; 2014 Mar; 59(6):1485-99. PubMed ID: 24594843
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow biopsy: RNA isolation with expression profiling in men with metastatic castration-resistant prostate cancer--factors affecting diagnostic success.
Spritzer CE; Afonso PD; Vinson EN; Turnbull JD; Morris KK; Foye A; Madden JF; Roy Choudhury K; Febbo PG; George DJ
Radiology; 2013 Dec; 269(3):816-23. PubMed ID: 23925271
[TBL] [Abstract][Full Text] [Related]
23. Impact of different standardized uptake value measures on PET-based quantification of treatment response.
Vanderhoek M; Perlman SB; Jeraj R
J Nucl Med; 2013 Aug; 54(8):1188-94. PubMed ID: 23776199
[TBL] [Abstract][Full Text] [Related]
24. [Discrepancies between primary tumor and metastasis: impact on personalized medicine].
Vignot S; Soria JC
Bull Cancer; 2013 Jun; 100(6):561-8. PubMed ID: 23728079
[TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing reveals high concordance of recurrent somatic alterations between primary tumor and metastases from patients with non-small-cell lung cancer.
Vignot S; Frampton GM; Soria JC; Yelensky R; Commo F; Brambilla C; Palmer G; Moro-Sibilot D; Ross JS; Cronin MT; André F; Stephens PJ; Lazar V; Miller VA; Brambilla E
J Clin Oncol; 2013 Jun; 31(17):2167-72. PubMed ID: 23630207
[TBL] [Abstract][Full Text] [Related]
26. Validation and clinical utility of prostate cancer biomarkers.
Scher HI; Morris MJ; Larson S; Heller G
Nat Rev Clin Oncol; 2013 Apr; 10(4):225-34. PubMed ID: 23459624
[TBL] [Abstract][Full Text] [Related]
27. Imaging of castration-resistant prostrate cancer: development of imaging response biomarkers.
Morisson C; Jeraj R; Liu G
Curr Opin Urol; 2013 May; 23(3):230-6. PubMed ID: 23422587
[TBL] [Abstract][Full Text] [Related]
28. The incidence and significance of multiple lesions in glioblastoma.
Thomas RP; Xu LW; Lober RM; Li G; Nagpal S
J Neurooncol; 2013 Mar; 112(1):91-7. PubMed ID: 23354652
[TBL] [Abstract][Full Text] [Related]
29. The impact of coaxial core biopsy guided by FDG PET/CT in oncological patients.
Cerci JJ; Pereira Neto CC; Krauzer C; Sakamoto DG; Vitola JV
Eur J Nucl Med Mol Imaging; 2013 Jan; 40(1):98-103. PubMed ID: 23100050
[TBL] [Abstract][Full Text] [Related]
30. The roots of cancer: stem cells and the basis for tumor heterogeneity.
Shibata M; Shen MM
Bioessays; 2013 Mar; 35(3):253-60. PubMed ID: 23027425
[TBL] [Abstract][Full Text] [Related]
31. Tumor lesion glycolysis and tumor lesion proliferation for response prediction and prognostic differentiation in patients with advanced non-small cell lung cancer treated with erlotinib.
Kahraman D; Holstein A; Scheffler M; Zander T; Nogova L; Lammertsma AA; Boellaard R; Neumaier B; Dietlein M; Wolf J; Kobe C
Clin Nucl Med; 2012 Nov; 37(11):1058-64. PubMed ID: 23027207
[TBL] [Abstract][Full Text] [Related]
32. Image-guided biopsy: what the interventional radiologist needs to know about PET/CT.
Kobayashi K; Bhargava P; Raja S; Nasseri F; Al-Balas HA; Smith DD; George SP; Vij MS
Radiographics; 2012; 32(5):1483-501. PubMed ID: 22977031
[TBL] [Abstract][Full Text] [Related]
33. The kinetics and reproducibility of 18F-sodium fluoride for oncology using current PET camera technology.
Kurdziel KA; Shih JH; Apolo AB; Lindenberg L; Mena E; McKinney YY; Adler SS; Turkbey B; Dahut W; Gulley JL; Madan RA; Landgren O; Choyke PL
J Nucl Med; 2012 Aug; 53(8):1175-84. PubMed ID: 22728263
[TBL] [Abstract][Full Text] [Related]
34. Discrepancies between primary tumor and metastasis: a literature review on clinically established biomarkers.
Vignot S; Besse B; André F; Spano JP; Soria JC
Crit Rev Oncol Hematol; 2012 Dec; 84(3):301-13. PubMed ID: 22710198
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer.
Chen HH; Chiu NT; Su WC; Guo HR; Lee BF
Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034
[TBL] [Abstract][Full Text] [Related]
36. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer.
Kim K; Kim SJ; Kim IJ; Kim YS; Pak K; Kim H
Nucl Med Commun; 2012 Jun; 33(6):613-20. PubMed ID: 22407127
[TBL] [Abstract][Full Text] [Related]
37. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Gerlinger M; Rowan AJ; Horswell S; Math M; Larkin J; Endesfelder D; Gronroos E; Martinez P; Matthews N; Stewart A; Tarpey P; Varela I; Phillimore B; Begum S; McDonald NQ; Butler A; Jones D; Raine K; Latimer C; Santos CR; Nohadani M; Eklund AC; Spencer-Dene B; Clark G; Pickering L; Stamp G; Gore M; Szallasi Z; Downward J; Futreal PA; Swanton C
N Engl J Med; 2012 Mar; 366(10):883-892. PubMed ID: 22397650
[TBL] [Abstract][Full Text] [Related]
38. Importance of confirming HER2 overexpression of recurrence lesion in breast cancer patients.
Nakamura R; Yamamoto N; Onai Y; Watanabe Y; Kawana H; Miyazaki M
Breast Cancer; 2013 Oct; 20(4):336-41. PubMed ID: 22367960
[TBL] [Abstract][Full Text] [Related]
39. To biopsy or not to biopsy: is that the only question?
Dawood S; Gonzalez-Angulo AM
Oncologist; 2012; 17(2):151-3. PubMed ID: 22267854
[TBL] [Abstract][Full Text] [Related]
40. Radiomics: extracting more information from medical images using advanced feature analysis.
Lambin P; Rios-Velazquez E; Leijenaar R; Carvalho S; van Stiphout RG; Granton P; Zegers CM; Gillies R; Boellard R; Dekker A; Aerts HJ
Eur J Cancer; 2012 Mar; 48(4):441-6. PubMed ID: 22257792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
